Overview Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea Status: Unknown status Trial end date: 2020-05-01 Target enrollment: Participant gender: Summary Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea Phase: Phase 2 Details Lead Sponsor: Pure Green